Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INEOS Group Holdings is a global chemical powerhouse that serves as a critical supplier to the pharmaceutical and healthcare industries. The company is a leading producer of high-purity solvents and active pharmaceutical ingredients (APIs), such as phenol, acetone, and alcohols used in the manufacture of essential medicines like aspirin and insulin. Through its INEOS Hygienics business, it provides hospital-grade hand sanitizers and surface disinfectants. Furthermore, INEOS has established a major partnership with the University of Oxford to create the Oxford-INEOS Institute, focusing on the development of new drugs to combat antimicrobial resistance. The company also manufactures specialized medical-grade polymers used in diagnostic equipment, drug delivery devices, and surgical tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INEOS Group Holdings.